美股详情

本页面由Tiger Trade Technology Pte. Ltd.提供服务

Recro Pharma Inc

2.09

0.0000

成交量：- -

成交额：29.69万

市值：9,742.44万

市盈率：-0.91

高：2.09

开：2.09

低：2.09

收：2.09

52周最高：3.79

52周最低：1.38

股本：4,661.45万

流通股本：3,668.56万

量比：- -

换手率：- -

股息：- -

股息率：- -

每股收益(TTM):-2.2909

每股收益(LYR):-3.8956

净资产收益率：1595.51%

总资产收益率：-5.38%

市净率：-5.00

市盈率(LYR):-0.54

数据加载中...

总览公司新闻资讯公告

公司资料

公司名字：

Recro Pharma Inc

交易所：

NASDAQ

成立时间：

- -

员工人数：

- -

公司地址：

- -

官网：

http://www.recropharma.com

邮编：

- -

电话：

- -

传真：

- -

简介：

Recro Pharma, Inc.是一家处于发展阶段的公司，于2007年11月15日与Recro第一制药公司合并。公司于2008年8月31日更名为Recro制药公司。该公司是一家专业制药公司，通过两个业务部门运营：急症护理部门和创收合同开发和制造部门或CDMO部门，通过该部门他们在乔治亚州的盖恩斯维尔运营创收制造工厂。他们认为，他们可以为患者，处方者和付款人（例如他们的首要产品候选者，注射用美洛昔康）带给医院和相关急性护理市场有价值的治疗选择。

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券 | 轻松买卖美股港股A股/美债/ETF/Crypto/期权期货","description":"老虎证券提供多项优惠：港股&Crypto 0佣、A股通一年免佣、美股期权0佣、IPO打新0融资利息0手续费。 美股1美元起投，免费实时行情与多种工具，立即开户享更多优惠！","keywords":"老虎证券,老虎证券开户,老虎证券香港,老虎证券登录,老虎证券官网,香港证券开户,证券公司开户,股票开户,香港证券公司,香港证券,证券公司,股票投资,投资app,投资平台,股票买卖,股票交易平台,股票app,证券app,新手投资","social":{"ogDescription":"老虎证券提供多项优惠：港股&Crypto 0佣、A股通一年免佣、美股期权0佣、IPO打新0融资利息0手续费。 美股1美元起投，免费实时行情与多种工具，立即开户享更多优惠！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/REPH/company"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"REPH","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"REPH\",,,,,undefined,":{"symbol":"REPH","market":"US","secType":"STK","nameCN":"Recro Pharma Inc","latestPrice":2.09,"timestamp":1647892800000,"preClose":2.09,"halted":8,"volume":0,"delay":0,"changeRate":0,"floatShares":36685639,"shares":46614535,"eps":-2.290947,"marketStatus":"交易中","change":0,"latestTime":"03-18 10:19:07 EDT","open":2.09,"high":2.09,"low":2.09,"amount":296933.780364,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.290947,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1773864000000},"marketStatusCode":2,"symbolChange":{"newSymbol":"SCTL","executeDate":"2022-03-22"},"adr":0,"adrRate":0,"listingDate":1394168400000,"exchange":"NASDAQ","adjPreClose":2.09,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"REPH\",,,,,undefined,":{"symbol":"REPH","floatShares":36685639,"roa":"-5.38%","roe":"1595.51%","lyrEps":-3.895557,"shares":46614535,"dividePrice":0,"high":2.09,"amplitude":0,"preClose":2.09,"low":2.09,"week52Low":1.38,"pbRate":"-5.00","week52High":3.79,"institutionHeld":0,"latestPrice":2.09,"eps":-2.290947,"divideRate":0,"volume":0,"delay":0,"ttmEps":-2.290947,"open":2.09},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/REPH\",params:#limit:5,,,undefined,":[{"market":"US","date":"2022-03-22","symbol":"REPH","oldSymbol":"REPH","defaultRemindTime":1647955800000,"newSymbol":"SCTL","exchange":"NASDAQ","type":"symbolChange","dateTimestamp":1647921600000},{"market":"US","date":"2022-03-01","symbol":"REPH","fiscalQuarterEnding":"2021/12","expectedEps":-0.07,"name":null,"time":"盘后","type":"earning","dateTimestamp":1646110800000,"reportTimeType":"post","actualEps":-0.04},{"market":"US","date":"2021-11-09","symbol":"REPH","fiscalQuarterEnding":"2021/09","expectedEps":-0.05,"name":null,"time":"盘后","type":"earning","dateTimestamp":1636434000000,"reportTimeType":"post","actualEps":-0.07},{"market":"US","date":"2021-08-09","symbol":"REPH","fiscalQuarterEnding":"2021/06","expectedEps":null,"name":null,"time":"盘后","type":"earning","dateTimestamp":1628481600000,"reportTimeType":"post","actualEps":-0.06},{"market":"US","date":"2021-05-06","symbol":"REPH","fiscalQuarterEnding":"2021/03","expectedEps":null,"name":null,"time":"盘后","type":"earning","dateTimestamp":1620273600000,"reportTimeType":"post","actualEps":-0.23}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"REPH\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"REPH\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{},"stockCompanyDetail":{"websiteUrl":"http://www.recropharma.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":0},{"period":"1year","weight":0},{"period":"ytd","weight":0}],"compareEarnings":[{"period":"1week","weight":-0.0094},{"period":"1month","weight":-0.0161},{"period":"3month","weight":-0.0009},{"period":"6month","weight":0.0129},{"period":"1year","weight":0.1827},{"period":"ytd","weight":-0.0163}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Recro Pharma, Inc.是一家处于发展阶段的公司，于2007年11月15日与Recro第一制药公司合并。公司于2008年8月31日更名为Recro制药公司。该公司是一家专业制药公司，通过两个业务部门运营：急症护理部门和创收合同开发和制造部门或CDMO部门，通过该部门他们在乔治亚州的盖恩斯维尔运营创收制造工厂。 他们认为，他们可以为患者，处方者和付款人（例如他们的首要产品候选者，注射用美洛昔康）带给医院和相关急性护理市场有价值的治疗选择。","yearOnYearQuotes":[{"month":1,"riseRate":0.375,"avgChangeRate":-0.018418},{"month":2,"riseRate":0.75,"avgChangeRate":0.018728},{"month":3,"riseRate":0.5,"avgChangeRate":0.15255},{"month":4,"riseRate":0.5,"avgChangeRate":0.067865},{"month":5,"riseRate":0.375,"avgChangeRate":-0.120099},{"month":6,"riseRate":0.625,"avgChangeRate":0.075849},{"month":7,"riseRate":0.5,"avgChangeRate":-0.018654},{"month":8,"riseRate":0.375,"avgChangeRate":0.041051},{"month":9,"riseRate":0.25,"avgChangeRate":-0.10177},{"month":10,"riseRate":0.125,"avgChangeRate":-0.058291},{"month":11,"riseRate":0.75,"avgChangeRate":0.068379},{"month":12,"riseRate":0.875,"avgChangeRate":0.060021}],"exchange":"NASDAQ","name":"Recro Pharma Inc","nameEN":"Recro Pharma"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"REPH\",market:\"US\",,,undefined,":null}}